Tissue-engineering of the gastrointestinal tract

Current Opinion in Pediatrics

Volumn 24, Issue 3, 2012, Pages 365-370

  Levin, Daniel E ^a   Grikscheit, Tracy C ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

esophagus; gastrointestinal system; intestinal stem cell; large intestine; Lgr5; pediatric surgery; short bowel syndrome; small intestine; stomach; tissue engineering

Indexed keywords

ANUS; COLON; ESOPHAGUS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRACT FUNCTION; HUMAN; NONHUMAN; NUTRITIONAL DEFICIENCY; PARENTERAL NUTRITION; PRIORITY JOURNAL; REVIEW; SHORT BOWEL SYNDROME; SMALL INTESTINE; STEM CELL; STOMACH; STOMACH CANCER; TISSUE ENGINEERING; TOTAL STOMACH RESECTION;

CHILD; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; REGENERATION; STEM CELLS; TISSUE ENGINEERING;

EID: 84861099980     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328352ec19     Document Type: Review

References (45)

1. Grikscheit TC, Siddique A, Ochoa ER, et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 2004;240:748-754.
2. Wales P, de Silva N, Kim J, et al. Neonatal short bowel syndrome: populationbased estimates of incidence and mortality rates. J Pediatr Surg 2004;39:690.
3. Schalamon J, Mayr JM, Hollwarth ME. Mortality and economics in short bowel syndrome. Best Pract Res Clin Gastroenterol 2003;17:931-942.
4. Peyret B, Collardeau S, Touzet S, et al. Prevalence of liver complications in children receiving long-term parenteral nutrition. Eur J Clin Nutr 2011;65:743-749.
5. Misiakos E, Macheras A, Kapetanakis T, Liakakos T. Short bowel syndrome: current medical and surgical trends. J Clin Gastroenterol 2007;41:5-18.
6. Potten C, Gandara R, Mahida Y, et al. The stem cells of the small intestinal crypts: where are they? Cell Proliferation 2009;42:731-750.
7. Cheng H, Leblond C. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am J Anat 1974;141:537-562.
8. Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. I. Evidence from Paneth cells in the adult mouse. Am J Anat 1981;160:51-63.
9. Kaur P, Potten C. Circadian variation in migration velocity in small intestinal epithelium. Cell Tissue Kinetics 1986;19:591-599.
10. Qiu J, Roberts S, Potten C. Cell migration in the small and large bowel shows a strong circadian rhythm. Epithelial Cell Biol 1994;3:137-148.
11. Potten C. Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc B Biol Sci 1998;353:821-830.
12. Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-1008.
13. Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009;459:262-265.
14. Sato T, van Es JH, Snippert H, et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011;469:415-418. Demonstrates that the Paneth cells support the Lgr5 (+) stem cell niche, as opposed to the mesenchyme, via expression of EGF, transforming growth factor (TGF)-α, Wnt3 and the Notch ligand Dll4.
15. Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nature Genet 2008;40:915-920.
16. Tian H, Biehs B, Warming S, et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 2011;478:255-259. Demonstrates Bmi1-expressing cells can repopulate the crypt base columnar cells after ablation of Lgr5 (+) cells, providing further evidence for the theory of two populations of intestinal stem cells, a quiescent and a rapidly cycling population.
17. Zhu L, Gibson P, Currle DS, et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009;457:603-607.
18. Asai R, Okan H, Yasugi S. Correlation between Musashi-1 and c-hairy-1 expression and cell proliferation activity in the developing intestine and stomach of both chicken and mouse. Dev Growth Differ 2005;47:501-510.
19. Montgomery R, Carlone D, Richmond C, et al. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci 2011;108:179-184.
20. May R, Sureban SM, Hoang N, et al. Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively. Stem Cells 2009;27:2571-2579.
21. Pusch J, Votteler M, Gö hler S, et al. The physiological performance of a three-dimensional model that mimics the microenvironment of the small intestine. Biomaterials 2011;32:7469-7478. A three-dimensional, dynamic culture system improves in-vitro tissue-enginered intestine in comparision to traditional static culture systems.
22. Salerno-Goncalves R, Fasano A, Sztein M. Engineering of a multicellular organotypic model of the human intestinal mucosa. Gastroenterology 2011;141:18-21. Produced an in-vitro epithelial lining, creating a novel method for studying intestinal cell signaling and response to infection.
23. Spence JR, Mayhew CN, Rankin SA, et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011;470:105-109. First to produce differentiated intestinal epithelial cells from induced pluripotent stem cells.
24. Vacanti J, Morse M, Saltzman W, et al. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 1988;23:3-9.
25. Evans G, Flint N, Somers A, et al. The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci 1992;101:219-231.
26. Sala FG, Matthews JA, Speer AL, et al. A multicellular approach forms a significant amount of tissue-engineered small intestine in the mouse. Tissue Eng Part A 2011;17:1841-1850. Introduced this technique for growing tissue-engineered small intestine into a mouse model, a necessary step for accessing the transgenic strains and investigation techniques available in mice.
27. Sala FG, Kunisaki SM, Ochoa ER, et al. Tissue-engineered small intestine and stomach form from autologous tissue in a preclinical large animal model. J Surg Res 2009;156:205-212.
28. Xu HM, Wang ZJ, Han JG, et al. Application of acellular dermal matrix for intestinal elongation in animal models. World J Gastroenterol 2010;16:2023-2027. A scaffold interposition alone (without cellular seeding) does not promote intestinal ingrowth from the proximal and distal segments and cannot be used for bowel elongation.
29. Nakase Y, Nakamura T, Kin S, et al. Intrathoracic eosphageal replacement by in situ tissue-engineered esophagus. J Thorac Cardiovasc Surg 2008;136:850-859.
30. Saxena A, Ainoedhofer H, Hollwarth M. Culture of ovine esophageal epithelial cells and in vitro esophagus tissue engineering. Tissue Eng Part C 2010;16:109-114. An esophageal epithelium grows on a collagen scaffold, a step toward growing fullthickness tissue-engineered esophagus.
31. Saxena A, Baumgart H, Komann C, et al. Esophagus tissue engineering: in situ generation of rudimentary tubular vascularized esophageal conduit using the ovine model. J Pediatr Surg 2010;45:859-864. Vascular ingrowth of an in-situ tissue-engineered esophagus demonstrates feasibility of providing blood supply to TEE.
32. Green N, Huang Q, Kahn L, et al. The development and characterization of an organotypic tissue-engineered human esophageal mucosal model. Tissue Eng Part A 2010;16:1053-1064. Identifies the ideal cellular source and scaffold for TEE among commonly used techniques.
33. Parkin D, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Cancer J Clin 2005;55:74-108.
34. Maemura T, Shin M, Sato M, et al. A tissue-engineered stomach as a replacement of the native stomach. Transplantation 2003;76:61-65.
35. Grikscheit T, Srinivasan A, Vacanti JP. Tissue-engineered stomach: a preliminary report of a versatile in vivo model with therapeutic potential. J Pediatr Surg 2003;38:1305-1309.
36. Maemura T, Shin M, Kinoshita M, et al. A tissue-engineered stomach shows presence of proton pump and G-cells in a rat model, resulting in improved anemia following total gastrectomy. Artif Organs 2008;32:234-239.
37. Barker N, Huch M, Kujala P, et al. Lgr5+ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010;6:25-36. Established Lgr5-expressing cells as markers of gastric stem cells.
38. Maemura T, Kinoshita M, Shin M, et al. Assessment of a tissueengineered gastric wall patch in a rat model. Artificial Organs 2011. [Epub ahead of print] Demonstrates feasibility of treating gastric wall defect with a tissue-engineered stomach wall patch.
39. Speer AL, Sala FG, Matthews JA, Grikscheit TC. Murine tissue-engineered stomach demonstrates epithelial differentiation. J Surg Res 2011;156:205-212. First to grow tissue-engineered stomach in a mouse. A necessary step to determine the molecular and cellular mechanisms of this regenerative process.
40. Grikscheit TC, Ochoa ER, Ramsanahie A, et al. Tissue-engineered large intestine resembles native colon with appropriate in vitro physiology and architecture. Ann Surg 2003;238:35-41.
41. Grikscheit TC, Ogilvie JB, Ochoa E, et al. Tissue-engineered colon exhibits function in vivo Surgery. 2002;132:200-204.
42. Hashish M, Raghavan S, Somara S, et al. Surgical implantation of a bioengineered internal anal sphincter. J Pediatr Surg 2010;45:52-58. Three-dimensional bioengineered internal anal sphincter can be generated.
43. Raghavan S, Miyasaka EA, Hashish M, et al. Successful implantation of physiologically functional bioengineered mouse internal anal sphincter. Am J Physiol Gastrointest Liver Physiol 2010;299:G430-G439. Bioengineered internal anal sphincter demonstrates basal tone with appropriate contraction and relaxation to cholinergic, nitrergic, and vasoactive intestinal peptide (VIP)-ergic stimulation.
44. Miyasaka E, Raghavan S, Gilmont RR, et al. In vivo growth of a bioengineered internal anal sphincter: comparison of growth factors for optimization of growth and survival. Pediatr Surg Int 2011;27:137-143. Growth factors, including PDGF (a drug already approved for use in the United States and European Union), improve growth of tissue-engineered internal anal sphincter.
45. Raghavan S, Gilmont RR, Miyasaka EA, et al. Successful implantation of bioengineered, intrinsically innervated, human internal anal sphincter. Gastroenterology 2011;141:310-319. A bioengineered human internal anal sphincter can be grown with intact nerve, blood vessel and functioning muscle.